| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.00019 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.00012 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.00014 | 1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 8e-05 | 1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -7.4e-05 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -6.8e-05 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 2.1e-05 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 2.7e-05 | 1 |